These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23918671)

  • 1. European Commission orders France to lift ban on acne pill.
    Arie S
    BMJ; 2013 Aug; 347():f4932. PubMed ID: 23918671
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral contraceptives, risks and hazards].
    Revuz J
    Ann Dermatol Venereol; 2014 Jan; 141(1):5-6. PubMed ID: 24461087
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyproterone acetate].
    Borelli C
    Hautarzt; 2002 Feb; 53(2):149. PubMed ID: 11963195
    [No Abstract]   [Full Text] [Related]  

  • 4. [Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
    Debarre JM
    Ann Dermatol Venereol; 2013; 140(6-7):474-8. PubMed ID: 23773753
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic cyproterone/ethinyloestradiol for acne.
    Marsden J; Shuster S
    Lancet; 1983 Sep; 2(8352):736-7. PubMed ID: 6136862
    [No Abstract]   [Full Text] [Related]  

  • 6. [A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
    Vignini M; Pelfini C; Montanari L
    Minerva Ginecol; 1988 Feb; 40(2):125-32. PubMed ID: 2969466
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):233-4. PubMed ID: 10394435
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
    Mehrl J
    Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
    Ann Dermatol Venereol; 1999 Mar; 126(3):224-31. PubMed ID: 10394434
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
    Vartiainen M; de Gezelle H; Broekmeulen CJ
    Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic cyproterone/ethinyloestradiol for acne.
    Lancet; 1983 Aug; 2(8347):458. PubMed ID: 6135942
    [No Abstract]   [Full Text] [Related]  

  • 12. Different effectiveness of cyproterone acetate doses in treatment of acne.
    De Leo V; Morgante G
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):246. PubMed ID: 12580942
    [No Abstract]   [Full Text] [Related]  

  • 13. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
    Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.
    Gruber DM; Sator MO; Joura EA; Kokoschka EM; Heinze G; Huber JC
    Arch Dermatol; 1998 Apr; 134(4):459-63. PubMed ID: 9554298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary embolism after short-term treatment of acne vulgaris with ovulation suppressor agents.
    Poran J; Guber A; Schindler D; Shachor Y
    Med J Aust; 1986 Oct; 145(7):345. PubMed ID: 2945082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The hypocrisy of Diane®].
    Revuz J
    Ann Dermatol Venereol; 2013 Apr; 140(4):249-50. PubMed ID: 23567222
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate.
    Palombo-Kinne E; Schellschmidt I; Schumacher U; Gräser T
    Contraception; 2009 Apr; 79(4):282-9. PubMed ID: 19272497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic cyproterone/ethinyloestradiol in acne.
    Bye P
    Lancet; 1983 Oct; 2(8355):910-1. PubMed ID: 6137719
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
    Franks S; Layton A; Glasier A
    Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
    Rubina VV; Korchevaia TA; Kravchenko LIa
    Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.